{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:18:56Z","timestamp":1794277136752,"version":"4.9.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS091219"],"award-info":[{"award-number":["NS091219"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS091219"],"award-info":[{"award-number":["NS091219"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012869","name":"Morgan Adams Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012869","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Morgan Adams Foundation Cancer League of Colorado"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65466-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:01:24Z","timestamp":1764079284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Bethany","family":"Veo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1058-4604","authenticated-orcid":false,"given":"John","family":"DeSisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0848-0494","authenticated-orcid":false,"given":"Angela","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breauna","family":"Brunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Chandra","family":"Bompada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Donson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Goodspeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiara","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Foreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5949-3896","authenticated-orcid":false,"given":"Rajeev","family":"Vibhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"65466_CR1","doi-asserted-by":"publisher","first-page":"JCO2001372","DOI":"10.1200\/JCO.20.01372","volume":"39","author":"A Gajjar","year":"2021","unstructured":"Gajjar, A. et al. Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03). J. Clin. Oncol. 39, JCO2001372 (2021).","journal-title":"J. Clin. Oncol."},{"key":"65466_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott, P. A. et al. The whole-genome landscape of medulloblastoma subtypes. Nature 547, 311\u2013317 (2017).","journal-title":"Nature"},{"key":"65466_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli, F. M. G. et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell 31, 737\u2013754.e6 (2017).","journal-title":"Cancer Cell"},{"key":"65466_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1200\/JCO.2010.28.5148","volume":"29","author":"YJ Cho","year":"2011","unstructured":"Cho, Y. J. et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 29, 1424\u20131430 (2011).","journal-title":"J. Clin. Oncol."},{"key":"65466_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/neuonc\/noae178","volume":"27","author":"EC Schwalbe","year":"2024","unstructured":"Schwalbe, E. C. et al. Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study. Neuro-Oncol. 27, 222\u2013236 (2024).","journal-title":"Neuro-Oncol."},{"key":"65466_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrclinonc.2014.181","volume":"11","author":"AJ Gajjar","year":"2014","unstructured":"Gajjar, A. J. & Robinson, G. W. Medulloblastoma-translating discoveries from the bench to the bedside. Nat. Rev. Clin. Oncol. 11, 714\u2013722 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"65466_CR7","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/pbc.21525","volume":"50","author":"G Dhall","year":"2008","unstructured":"Dhall, G. et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the \u201cHead Start\u201d I and II protocols. Pediatr. Blood Cancer 50, 1169\u20131175 (2008).","journal-title":"Pediatr. Blood Cancer"},{"key":"65466_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S2352-4642(20)30246-7","volume":"4","author":"RM Hill","year":"2020","unstructured":"Hill, R. M. et al. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study. Lancet Child Adolesc. Heal. 4, 865\u2013874 (2020).","journal-title":"Lancet Child Adolesc. Heal."},{"key":"65466_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/cancers13010053","volume":"13","author":"S Huybrechts","year":"2020","unstructured":"Huybrechts, S. et al. Prognostic clinical and biologic features for overall survival after relapse in childhood medulloblastoma. Cancers 13, 53 (2020).","journal-title":"Cancers"},{"key":"65466_CR10","doi-asserted-by":"crossref","unstructured":"Johnston, D. L. et al. Survival Following Tumor Recurrence in Children With Medulloblastoma. J. Pediatr. Hematol.solOncol. 40, e159\u2013e163 (2018).","DOI":"10.1097\/MPH.0000000000001095"},{"key":"65466_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"65466_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature16478","volume":"529","author":"AS Morrissy","year":"2016","unstructured":"Morrissy, A. S. et al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529, 351\u2013357 (2016).","journal-title":"Nature"},{"key":"65466_CR13","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-22-2108","volume":"82","author":"A Borgenvik","year":"2022","unstructured":"Borgenvik, A. et al. Dormant SOX9-positive cells facilitate MYC-driven recurrence of medulloblastoma. Cancer Res 82, 4586\u20134603 (2022).","journal-title":"Cancer Res"},{"key":"65466_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/neuonc\/noab135","volume":"24","author":"KA Riemondy","year":"2021","unstructured":"Riemondy, K. A. et al. Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro-Oncol. 24, 273\u2013286 (2021).","journal-title":"Neuro-Oncol."},{"key":"65466_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41586-019-1434-6","volume":"572","author":"V Hovestadt","year":"2019","unstructured":"Hovestadt, V. et al. Resolving medulloblastoma cellular architecture by single-cell genomics. Nature 572, 74\u201379 (2019).","journal-title":"Nature"},{"key":"65466_CR16","doi-asserted-by":"publisher","first-page":"111162","DOI":"10.1016\/j.celrep.2022.111162","volume":"40","author":"D Williamson","year":"2022","unstructured":"Williamson, D. et al. Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development. Cell Rep. 40, 111162 (2022).","journal-title":"Cell Rep."},{"key":"65466_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/neuonc\/noab178","volume":"24","author":"S Richardson","year":"2021","unstructured":"Richardson, S. et al. Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse. Neuro-Oncol. 24, 153\u2013165 (2021).","journal-title":"Neuro-Oncol."},{"key":"65466_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi5568","volume":"7","author":"D Bakhshinyan","year":"2021","unstructured":"Bakhshinyan, D. et al. Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence. Sci. Adv. 7, eabi5568 (2021).","journal-title":"Sci. Adv."},{"key":"65466_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1517\/13543784.2011.546344","volume":"20","author":"R Barouch-Bentov","year":"2011","unstructured":"Barouch-Bentov, R. & Sauer, K. Mechanisms of drug resistance in kinases. Expert Opin. Investig. Drugs 20, 153\u2013208 (2011).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"65466_CR20","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1158\/1078-0432.CCR-14-1213","volume":"21","author":"A Pribluda","year":"2015","unstructured":"Pribluda, A., Cruz, C. C. dela & Jackson, E. L. Intratumoral heterogeneity: from diversity comes resistance. Clin. Cancer Res 21, 2916\u20132923 (2015).","journal-title":"Clin. Cancer Res"},{"key":"65466_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fonc.2020.00296","volume":"10","author":"TB Garcia","year":"2020","unstructured":"Garcia, T. B. et al. Increased HDAC activity and c-MYC expression mediate acquired resistance to wee1 inhibition in acute leukemia. Front. Oncol. 10, 296 (2020).","journal-title":"Front. Oncol."},{"key":"65466_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2012.03.024","volume":"322","author":"C Moncharmont","year":"2012","unstructured":"Moncharmont, C. et al. Targeting a cornerstone of radiation resistance: cancer stem cell. Cancer Lett. 322, 139\u2013147 (2012).","journal-title":"Cancer Lett."},{"key":"65466_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/stem.318","volume":"28","author":"F Pajonk","year":"2010","unstructured":"Pajonk, F., Vlashi, E. & McBride, W. H. Radiation resistance of cancer stem cells: the 4 R\u2019s of radiobiology revisited. Stem Cells 28, 639\u2013648 (2010).","journal-title":"Stem Cells"},{"key":"65466_CR24","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1016\/j.cell.2021.07.039","volume":"184","author":"AE Trevino","year":"2021","unstructured":"Trevino, A. E. et al. Chromatin and gene-regulatory dynamics of the developing human cerebral cortex at single-cell resolution. Cell 184, 5053\u20135069.e23 (2021).","journal-title":"Cell"},{"key":"65466_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41593-020-00794-1","volume":"24","author":"UC Eze","year":"2021","unstructured":"Eze, U. C., Bhaduri, A., Haeussler, M., Nowakowski, T. J. & Kriegstein, A. R. Single-cell atlas of early human brain development highlights heterogeneity of human neuroepithelial cells and early radial glia. Nat. Neurosci. 24, 584\u2013594 (2021).","journal-title":"Nat. Neurosci."},{"key":"65466_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccell.2019.07.009","volume":"36","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Single-cell transcriptomics in medulloblastoma reveals tumor-initiating progenitors and oncogenic cascades during tumorigenesis and relapse. Cancer Cell 36, 302\u2013318.e7 (2019).","journal-title":"Cancer Cell"},{"key":"65466_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-022-05487-2","volume":"612","author":"Z Luo","year":"2022","unstructured":"Luo, Z. et al. Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis. Nature 612, 787\u2013794 (2022).","journal-title":"Nature"},{"key":"65466_CR28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41586-022-05215-w","volume":"609","author":"LD Hendrikse","year":"2022","unstructured":"Hendrikse, L. D. et al. Failure of human rhombic lip differentiation underlies medulloblastoma formation. Nature 609, 1021\u20131028 (2022).","journal-title":"Nature"},{"key":"65466_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41422-018-0053-3","volume":"28","author":"X Fan","year":"2018","unstructured":"Fan, X. et al. Spatial transcriptomic survey of human embryonic cerebral cortex by single-cell RNA-seq analysis. Cell Res 28, 730\u2013745 (2018).","journal-title":"Cell Res"},{"key":"65466_CR30","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41586-022-05208-9","volume":"609","author":"KS Smith","year":"2022","unstructured":"Smith, K. S. et al. Unified rhombic lip origins of group 3 and group 4 medulloblastoma. Nature 609, 1012\u20131020 (2022).","journal-title":"Nature"},{"key":"65466_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0959-4388(00)00177-X","volume":"11","author":"RJT Wingate","year":"2001","unstructured":"Wingate, R. J. T. The rhombic lip and early cerebellar development. Curr. Opin. Neurobiol. 11, 82\u201388 (2001).","journal-title":"Curr. Opin. Neurobiol."},{"key":"65466_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","volume":"27","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat. Med. 27, 141\u2013151 (2021).","journal-title":"Nat. Med."},{"key":"65466_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"65466_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1200\/JCO.2013.50.9539","volume":"32","author":"DJ Shih","year":"2014","unstructured":"Shih, D. J. et al. Cytogenetic prognostication within medulloblastoma subgroups. J. Clin. Oncol. 32, 886\u2013896 (2014).","journal-title":"J. Clin. Oncol."},{"key":"65466_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-023-01504-1","volume":"11","author":"K Okonechnikov","year":"2023","unstructured":"Okonechnikov, K. et al. Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses. Acta Neuropathol. Commun. 11, 7 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"65466_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-024-01601-1","volume":"17","author":"W-F Zuo","year":"2024","unstructured":"Zuo, W.-F. et al. Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies. J. Hematol. Oncol. 17, 81 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"65466_CR37","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/cancers16081500","volume":"16","author":"D Kunachowicz","year":"2024","unstructured":"Kunachowicz, D. et al. Heat shock proteins, a double-edged sword: significance in cancer progression, chemotherapy resistance and novel therapeutic perspectives. Cancers 16, 1500 (2024).","journal-title":"Cancers"},{"key":"65466_CR38","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1021\/acsmedchemlett.7b00342","volume":"8","author":"YS Cho","year":"2017","unstructured":"Cho, Y. S. et al. Discovery and evaluation of clinical candidate idh305, a brain penetrant mutant IDH1 inhibitor. ACS Med. Chem. Lett. 8, 1116\u20131121 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"65466_CR39","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.1021\/acs.jmedchem.8b00305","volume":"61","author":"CG Jakob","year":"2018","unstructured":"Jakob, C. G. et al. Novel modes of inhibition of wild-type isocitrate dehydrogenase 1 (idh1): direct covalent modification of His315. J. Med. Chem. 61, 6647\u20136657 (2018).","journal-title":"J. Med. Chem."},{"key":"65466_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-0752-3","volume":"18","author":"DS Dunican","year":"2020","unstructured":"Dunican, D. S. et al. Bivalent promoter hypermethylation in cancer is linked to the H327me3\/H3K4me3 ratio in embryonic stem cells. BMC Biol. 18, 25 (2020).","journal-title":"BMC Biol."},{"key":"65466_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tig.2019.11.004","volume":"36","author":"E Blanco","year":"2020","unstructured":"Blanco, E., Gonz\u00e1lez-Ram\u00edrez, M., Alcaine-Colet, A., Aranda, S. & Croce, L. D. The bivalent genome: characterization, structure, and regulation. Trends Genet 36, 118\u2013131 (2020).","journal-title":"Trends Genet"},{"key":"65466_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41580-022-00518-2","volume":"24","author":"TA Macrae","year":"2023","unstructured":"Macrae, T. A., Fothergill-Robinson, J. & Ramalho-Santos, M. Regulation, functions and transmission of bivalent chromatin during mammalian development. Nat. Rev. Mol. Cell Biol. 24, 6\u201326 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"65466_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00401-012-1069-2","volume":"125","author":"J Bunt","year":"2013","unstructured":"Bunt, J. et al. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels. Acta Neuropathol. 125, 385\u2013394 (2013).","journal-title":"Acta Neuropathol."},{"key":"65466_CR44","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","volume":"24","author":"M Russo","year":"2024","unstructured":"Russo, M. et al. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nat. Rev. Cancer 24, 694\u2013717 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"65466_CR45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41571-023-00815-5","volume":"20","author":"Y Pu","year":"2023","unstructured":"Pu, Y. et al. Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nat. Rev. Clin. Oncol. 20, 799\u2013813 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"65466_CR46","doi-asserted-by":"publisher","unstructured":"Okonechnikov, K. et al. Oncogene aberrations drive medulloblastoma progression, not initiation. Nature 1\u201311 https:\/\/doi.org\/10.1038\/s41586-025-08973-5 (2025).","DOI":"10.1038\/s41586-025-08973-5"},{"key":"65466_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature13981","volume":"518","author":"BW Carey","year":"2015","unstructured":"Carey, B. W., Finley, L. W., Cross, J. R., Allis, C. D. & Thompson, C. B. Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518, 413\u2013416 (2015).","journal-title":"Nature"},{"key":"65466_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tcb.2020.09.010","volume":"31","author":"SC Baksh","year":"2021","unstructured":"Baksh, S. C. & Finley, L. W. S. Metabolic Coordination of Cell Fate by \u03b1-Ketoglutarate-Dependent Dioxygenases. Trends Cell Biol. 31, 24\u201336 (2021).","journal-title":"Trends Cell Biol."},{"key":"65466_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41388-021-02056-1","volume":"41","author":"G Alzial","year":"2022","unstructured":"Alzial, G. et al. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene 41, 613\u2013621 (2022).","journal-title":"Oncogene"},{"key":"65466_CR50","doi-asserted-by":"publisher","unstructured":"Dang, D. et al. Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis. Cancer Cell https:\/\/doi.org\/10.1016\/j.ccell.2025.04.013 (2025).","DOI":"10.1016\/j.ccell.2025.04.013"},{"key":"65466_CR51","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.celrep.2017.05.014","volume":"19","author":"AE Calvert","year":"2017","unstructured":"Calvert, A. E. et al. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation. Cell Rep. 19, 1858\u20131873 (2017).","journal-title":"Cell Rep."},{"key":"65466_CR52","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1158\/0008-5472.CAN-23-1895","volume":"84","author":"M Zarei","year":"2024","unstructured":"Zarei, M. et al. IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer. Cancer Res 84, 3072\u20133085 (2024).","journal-title":"Cancer Res"},{"key":"65466_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade4113","volume":"15","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. Sci. Transl. Med. 15, eade4113 (2023).","journal-title":"Sci. Transl. Med."},{"key":"65466_CR54","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s43018-022-00393-y","volume":"3","author":"A Vaziri-Gohar","year":"2022","unstructured":"Vaziri-Gohar, A. et al. Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors. Nat. Cancer 3, 852\u2013865 (2022).","journal-title":"Nat. Cancer"},{"key":"65466_CR55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","volume":"28","author":"CL Jones","year":"2021","unstructured":"Jones, C. L., Inguva, A. & Jordan, C. T. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell 28, 378\u2013393 (2021).","journal-title":"Cell Stem Cell"},{"key":"65466_CR56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","volume":"1","author":"AM Intlekofer","year":"2019","unstructured":"Intlekofer, A. M. & Finley, L. W. S. Metabolic signatures of cancer cells and stem cells. Nat. Metab. 1, 177\u2013188 (2019).","journal-title":"Nat. Metab."},{"key":"65466_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495\u2013501 (2010).","journal-title":"Nat. Biotechnol."},{"key":"65466_CR58","doi-asserted-by":"publisher","first-page":"e1010378","DOI":"10.1371\/journal.pcbi.1010378","volume":"18","author":"Y Tanigawa","year":"2022","unstructured":"Tanigawa, Y., Dyer, E. S. & Bejerano, G. WhichTF is functionally important in your open chromatin data?. PLoS Comput. Biol. 18, e1010378 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"65466_CR59","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"65466_CR60","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res"},{"key":"65466_CR61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 14, 128 (2013).","journal-title":"BMC Bioinform"},{"key":"65466_CR62","doi-asserted-by":"crossref","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10, 1523 (2019).","DOI":"10.1038\/s41467-019-09234-6"},{"key":"65466_CR63","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496\u2013502 (2019).","journal-title":"Nature"},{"key":"65466_CR64","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"65466_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"65466_CR66","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov 2, 100141 (2021).","journal-title":"Innov"},{"key":"65466_CR67","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"65466_CR68","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"65466_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41592-018-0046-7","volume":"15","author":"TB Team","year":"2018","unstructured":"Team, T. B. et al. Bioconda: sustainable and comprehensive software distribution for the life sciences. Nat. Methods 15, 475\u2013476 (2018).","journal-title":"Nat. Methods"},{"key":"65466_CR70","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1093\/bioinformatics\/btx192","volume":"33","author":"F Leprevost","year":"2017","unstructured":"Leprevost, F. et al. BioContainers: an open-source and community-driven framework for software standardization. Bioinformatics 33, 2580\u20132582 (2017).","journal-title":"Bioinformatics"},{"key":"65466_CR71","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv 060012 https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"65466_CR72","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database Hallmark Gene Set Collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"65466_CR73","doi-asserted-by":"publisher","unstructured":"Dolgalev, I. msigdbr: MSigDB Gene Sets for Multiple Organisms in a Tidy Data Format. CRAN: Contrib. Packag. https:\/\/doi.org\/10.32614\/cran.package.msigdbr (2018).","DOI":"10.32614\/cran.package.msigdbr"},{"key":"65466_CR74","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"65466_CR75","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/neuonc\/noac219","volume":"25","author":"R Fu","year":"2022","unstructured":"Fu, R. et al. Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma. Neuro-Oncol. 25, 786\u2013798 (2022).","journal-title":"Neuro-Oncol."},{"key":"65466_CR76","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"65466_CR77","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu, Y. & Smyth, G. K. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70\u201378 (2009).","journal-title":"J. Immunol. Methods"},{"key":"65466_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-9236-2_2","volume":"1978","author":"T Nemkov","year":"2019","unstructured":"Nemkov, T., Reisz, J. A., Gehrke, S., Hansen, K. C. & D\u2019Alessandro, A. High-throughput metabolomics: isocratic and gradient mass spectrometry-based methods. Methods Mol. Biol. 1978, 13\u201326 (2019).","journal-title":"Methods Mol. Biol."},{"key":"65466_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48009-6","volume":"15","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics. Nat. Commun. 15, 3675 (2024).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65466-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:05:09Z","timestamp":1764083109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65466-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65466"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65466-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5522707\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10470"}}